![Erik Akhund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Akhund
Corporate Officer/Principal chez Quadrant Capital Advisors, Inc.
Profil
Erik Akhund is currently a Managing Director at Quadrant Capital Advisors, Inc. He was previously a Director at Melinta Subsidiary Corp.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York and an MBA from INSEAD.
Postes actifs de Erik Akhund
Sociétés | Poste | Début |
---|---|---|
Quadrant Capital Advisors, Inc.
![]() Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Erik Akhund
Sociétés | Poste | Fin |
---|---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | - |
Formation de Erik Akhund
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Quadrant Capital Advisors, Inc.
![]() Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Finance |